Evaluation of variable new antigen receptors (vNARs) as a novel cathepsin S (CTSS) targeting strategy

Evaluation of variable new antigen receptors (vNARs) as a novel cathepsin S (CTSS) targeting strategy

Aberrant activity of the cysteine protease Cathepsin S (CTSS) has been implicated across a wide range of pathologies. Notably in cancer, CTSS has been shown to promote tumour progression, primarily through facilitating invasion and migration of tumour cells and augmenting angiogenesis. Whilst an att...

Deskribapen osoa

Xehetasun bibliografikoak
Egile Nagusiak: P. Smyth, L. Ferguson, J. F. Burrows, R. E. Burden, S. R. Tracey, Ú. M. Herron, M. Kovaleva, R. Williams, A. J. Porter, D. B. Longley, C. J. Barelle, C. J. Scott
Formatua: Artikulua
Hizkuntza:English
Argitaratua: Frontiers Media S.A. 2023-12-01
Saila:Frontiers in Pharmacology
Gaiak:
therapeutic
cancer
inhibitor
vNAR
cathepsin
Sarrera elektronikoa:https://www.frontiersin.org/articles/10.3389/fphar.2023.1296567/full

Internet

https://www.frontiersin.org/articles/10.3389/fphar.2023.1296567/full

Antzeko izenburuak